Clinical trial

LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer

NCT06778512

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2019-06-01

PhaseN/A

Study timeline

Study start (actual)2019-06-01Date precision: day

Registry last updated2025-01-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lungunresolved

Lung Cancerverified · MONDO: lung cancer

Cancerverified · MONDO: cancer

NSCLCverified · MONDO: non-small cell lung carcinoma

Interventions

Using tissue and peripheral blood proteomics to distinguish the benign and malignant nature of lung cancer in patients, as well as to evaluate therapeutic efficacy and long-term prognosis during the tOTHER

Sponsors & collaborators

The First Affiliated Hospital of Guangzhou Medical Universitylead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06778512 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.